within Pharmacolibrary.Drugs.ATC.S;

model S01XA25
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.006966666666666666,
    adminDuration  = 600,
    adminMass      = 5.0 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0128,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01XA25</td></tr><td>route:</td><td>ophthalmic</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Lifitegrast is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the treatment of dry eye disease (keratoconjunctivitis sicca) in adults. It is administered as a topical ophthalmic solution and is FDA-approved for this use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are largely available from clinical summaries and product labels, as systemic exposure is minimal following ophthalmic administration. Population: Generally healthy adult subjects, both sexes, age ~18-80, normal renal and hepatic function, with dry eye disease.</p><h4>References</h4><ol><li><p>Donnenfeld, ED, et al., &amp; Rosenberg, ED (2017). Lifitegrast for the treatment of dry eye disease in adults. <i>Expert opinion on pharmacotherapy</i> 18(14) 1517–1524. DOI:<a href=\"https://doi.org/10.1080/14656566.2017.1372748\">10.1080/14656566.2017.1372748</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28841079/\">https://pubmed.ncbi.nlm.nih.gov/28841079</a></p></li><li><p>Chung, JK, et al., &amp; Welty, D (2018). Ocular Distribution and Pharmacokinetics of Lifitegrast in Pigmented Rabbits and Mass Balance in Beagle Dogs. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 34(1-2) 224–232. DOI:<a href=\"https://doi.org/10.1089/jop.2017.0106\">10.1089/jop.2017.0106</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29267138/\">https://pubmed.ncbi.nlm.nih.gov/29267138</a></p></li><li><p>Kim, E, et al., &amp; Kim, TH (2023). Establishment of an LC-MS/MS method for quantification of lifitegrast in rabbit plasma and ocular tissues and its application to pharmacokinetic study. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 1229 123892–None. DOI:<a href=\"https://doi.org/10.1016/j.jchromb.2023.123892\">10.1016/j.jchromb.2023.123892</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37788538/\">https://pubmed.ncbi.nlm.nih.gov/37788538</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01XA25;
